Edition:
India

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

50.15USD
5 Dec 2016
Change (% chg)

$-0.55 (-1.08%)
Prev Close
$50.70
Open
$50.85
Day's High
$51.45
Day's Low
$49.85
Volume
83,333
Avg. Vol
85,210
52-wk High
$59.29
52-wk Low
$29.60

CBM.N

Chart for CBM.N

About

Cambrex Corporation (Cambrex) is a life sciences company. The Company provides products and services for the development and commercialization of new and generic therapeutics. The Company supplies its products and services across the world to generic pharmaceutical companies. Cambrex operates through three segments, which are... (more)

Overall

Beta: 1.91
Market Cap(Mil.): $1,591.44
Shares Outstanding(Mil.): 32.15
Dividend: --
Yield (%): --

Financials

  CBM.N Industry Sector
P/E (TTM): 24.37 29.13 29.87
EPS (TTM): 2.03 -- --
ROI: 15.50 15.56 14.95
ROE: 20.47 16.69 16.29

BRIEF-Cambrex reports Q3 GAAP earnings per share $0.42 from continuing operations

* Says company expects full year 2016 sales, excluding impact of foreign currency, to increase between 12% and 14% compared to 2015.

04 Nov 2016

BRIEF-Cambrex Corp appoints Bernhard Hampl to the board of directors

* Bernhard Hampl appointed to the board of directors of Cambrex Corporation Source text for Eikon: Further company coverage:

31 Oct 2016

BRIEF-Cambrex to acquire Pharmacore to expand clinical stage API capabilities

* Cambrex to acquire Pharmacore Inc to expand clinical stage API capabilities

26 Sep 2016

BRIEF-Cambrex Q2 gaap earnings per share $0.63 from continuing operations

* Fy2016 earnings per share view $2.56, revenue view $475.4 million -- Thomson Reuters I/B/E/S

28 Jul 2016

BRIEF-Cambrex completes $50 mln investment in Iowa

* Cambrex completes $50 million investment in large scale API manufacturing and storage at its Charles City, Iowa Site Source text for Eikon: Further company coverage:

12 Jul 2016

Earnings vs. Estimates